Navigation Links
GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
Date:12/19/2007

ATLANTA, Dec. 19 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based biotechnology company developing HIV-1/AIDS vaccines, announced today that it has retained Financial Relations Board (FRB), as its Investor and Public Relations agency of record.

"GeoVax's promising HIV-1/AIDS vaccine human trial results need to be conveyed to those inflicted or threatened by the catastrophic AIDS pandemic," stated Kathy Waller, co-president of FRB.

GeoVax selected FRB to deliver its very important message to those interested in the potential "control" of AIDS through administration of GeoVax vaccines which are currently in their 5th successful human trial. Many individuals throughout the world were greatly concerned by recent disappointing human trial failures of other key HIV/AIDS vaccine developers that utilized vaccine technologies quite different than those of GeoVax. FRB's task will be to raise awareness of those significant differences. The media and investor information program as well as progress reports on GeoVax current and upcoming human trials will be conveyed on a regular basis. Media for the campaign may include print, television, radio and online information.

"We wanted to engage a firm that could effectively present the GeoVax story to current and prospective shareholders and to the media, while helping to educate the world about the crucial role that innovative vaccine technologies play in the fight against the global AIDS epidemic," said Dr. Harriet Robinson, GeoVax co-founder/Chief Scientist.

"We look forward to being part of a team that will highlight GeoVax's work in the frontline battle against HIV," said FRB's Kathy Waller. "FRB's broad expertise in the biotech and healthcare industries will effectively convey the company's vaccine development successes both to The Street and media communities."

About GeoVax Labs, Inc. (http://www.geov
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
2. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
3. Excellent Results Received from GeoVaxs Full-Dose HIV/AIDS Vaccine Trial
4. GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update
5. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
6. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
7. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
8. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. Progen Pharmaceuticals Announces Fiscal 2007 Financial Results
11. Biopure Announces 2007 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... -- ResMed (NYSE: RMD ) today announced its ... device manufacturer BMC Medical Co., Ltd. The ... below infringe ResMed,s patents, and entered an order prohibiting BMC ... the United States : , iVolve nasal ... nasal pillows mask , iVolve full face mask ...
(Date:12/24/2014)... 2014   Assurex Health, a personalized medicine ... providers for behavioral health and chronic pain conditions, ... in equity financing from new and existing investors, ... and Chief Executive Officer. The financing ... Assurex Health,s GeneSight ®  products.  GeneSight,s ...
(Date:12/24/2014)... , Dec. 23, 2014 Tianyin ... company that specializes in patented biopharmaceutical, modernized traditional ... ingredients (API) today announced that the Company achieved ... Good Manufacturing Practice (GMP) certificate of TPI,s Qionglai ... Administration,s (CFDA). The public notice period is a ...
Breaking Medicine Technology:ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3
... BEACH, Fla., June 27, 2011 Implementing an EHR system ... for a doctor that wants to attain Meaningful Use(1), but ... ongoing effort to assist doctors in their migration from paper ... three key services to Medical Messenger customers: ...
... GAITHERSBURG, Md., June 27, 2011 /PRNewswire-USNewswire / -- ... new service for people with Acute Lymphoblastic Leukemia ... refund eligible patients 100 percent of any co-pay ... information on eligibility criteria, please call 1-800-490-3262, Monday ...
Cached Medicine Technology:Medical Messenger Partners With ComputerAssistant.com to Provide Key Elements of Meaningful Use Success 2Financial Assistance Now Available for People with Acute Lymphoblastic Leukemia 2Financial Assistance Now Available for People with Acute Lymphoblastic Leukemia 3Financial Assistance Now Available for People with Acute Lymphoblastic Leukemia 4
(Date:12/25/2014)... When head lice hits a home or school, parents and ... of it while keeping it from taking over the house ... solution right in their neighborhood: Lice Troopers . Expanding ... spectrum head lice screening and treatment services to families and ... Brickell, Coconut Grove, Kendall, Pinecrest and South Miami. , The ...
(Date:12/25/2014)... Dennis Thompson HealthDay ... Very sick children with complex chronic illnesses can receive effective, ... "medical home," with easy access to a team of dedicated ... less likely to become seriously ill and need either hospitalization ... treatment at an enhanced medical home clinic at the University ...
(Date:12/25/2014)... Dec. 25, 2014 (HealthDay News) -- Overeating is common during ... eat in moderation, an expert says. "Don,t arrive at ... calories if you know you,ll be attending a party, but ... Ashbey-Pejoves, lead dietitian at Northern Westchester Hospital in Mount Kisco, ... to eat healthy during the day and even to have ...
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, 2014 ... "fountain of youth" drug that can delay the effects of ... study suggests. Seniors received a significant boost to their ... signaling pathway linked to aging and immune function, researchers with ... medication, a version of the drug rapamycin, improved the seniors, ...
(Date:12/25/2014)... December 25, 2014 Thousands of transvaginal ... forward in a number of multidistrict litigations currently underway ... Bernstein Liebhard LLP reports. According to an Order issued ... convene a Joint Status Conference in all of the ... have been directed to submit a proposed agenda to ...
Breaking Medicine News(10 mins):Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4
... payors to compete like ... marketplace, BURLINGTON, Mass., Nov. 13 HealthEdge, ... healthcare payors,today announced that it will showcase its ... Healthcare Summit. The,conference will be held on November ...
... cancer whose disease has progressed following chemotherapy have ... longer interval before cancer progression when bevacizumab is ... a study presented at the 2008 Chicago Multidisciplinary ... IASLC and the University of Chicago. , Bevacizumab ...
... are one milliard of a metre in size are ... materials. There are also significant amounts of nanoparticles in ... their health effects, because only a very small portion ... and safety risks. Nanoparticles have even been dubbed the ...
... a statement,by the National Patient Advocate Foundation ... Advocate Foundation (NPAF) congratulates,President-Elect Barack Obama (D-IL) ... election. NPAF, as the public policy voice ... direct patient services organization,servicing over 45,000 patient ...
... Caregiver Month, NAPLES, Fla., Nov. 13 In ... a deserving caregiver,s life,a little easier. AgingCare.com is holding ... enter the contest, family caregivers are asked to describe ... their,loved one, some upbeat wisdom that might help others, ...
... drug costs with funding from pharmaceutical,manufacturers, BETHESDA, ... announced the launch of a Cystic Fibrosis Patient,Assistance ... pay,for certain high-cost medications they cannot afford., ... exclusively by,pharmaceutical manufacturers. No dollars donated to the ...
Cached Medicine News:Health News:HealthEdge(R) Presents Award-Winning HealthRules(R) Technology Platform at the 2008 Gartner Healthcare Summit 2Health News:Nanoparticles trigger cell death? 2Health News:Statement by the National Patient Advocate Foundation on President-Elect Obama's Victory 2Health News:People Caring for Aging Parents Can Win $2,000 of Free Housecleaning 2Health News:Cystic Fibrosis Foundation Establishes Landmark Patient Assistance Foundation 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: